Top tip for healthspan Dr
On a section of its website devoted directly to compounded GLP-1 medications, 2 FDA makes the following recommendations to consumers: Carefully check labels for spelling errors or incorrect addresses
Millions of patients start GLP-1 therapy expecting consistent weight loss, yet approximately 3040% experience a plateau within 612 months despite continued medication use
Therefore, the risk of hypoglycemia is minimized because insulin release is not triggered when blood sugar is within the normal or low range
Kubota, S., Liu, Y., Iizuka, K., Kuwata, H., Seino, Y., & Yabe, D
If a medication or autoimmune problem is causing the deficiency, then the patient may need ongoing injections after that, but with some training most patients can administer the shots themselves